Skip to content
Conference

Explainable AI in Personalized Medicine: Bridging Patient Data and Clinical Decisions

Jul 2026 · 2026 International Conference on Emerging Trends in Information, Communication & Systems (ICETICS) · pp. 1-7 · 0 citations · 13 references

Abstract

Personalized medicine aims to tailor prevention, diagnosis, and treatment strategies to individual patients by leveraging heterogeneous data sources such as electronic health records, medical imaging, genomic profiles, and real-time physiological signals. Although artificial intelligence has demonstrated remarkable predictive performance in this domain, the widespread clinical adoption of such models remains constrained by their black-box nature, limited transparency, and lack of trust among clinicians and patients. Explainable Artificial Intelligence (XAI) has emerged as a critical paradigm to address these limitations by providing interpretable, transparent, and clinically meaningful insights into model behavior and decision logic. This paper presents a comprehensive examination of explainable AI in personalized medicine, focusing on its role in bridging complex patient data with actionable clinical decisions. The study discusses major XAI methodologies, including intrinsic interpretability models and post hoc explanation techniques, and evaluates their applicability across key medical use cases such as disease risk prediction, treatment response modeling, and clinical decision support systems. Furthermore, challenges related to data heterogeneity, model generalization, ethical compliance, and regulatory acceptance are analyzed. By integrating explainability with predictive accuracy, XAI-driven frameworks have the potential to enhance clinical confidence, support evidence-based decision-making, and improve patientcentric outcomes. The paper concludes by outlining future research directions toward scalable, trustworthy, and regulation-compliant explainable AI systems for next-generation personalized healthcare.

View source

Similar papers

Open access 2021

Data Science Approaches to Personalized Healthcare

Future research focuses on integrating Internet of Medical Things (IoMT) devices, real-time monitoring, and federated learning to enable privacy-preserving collaboration across healthcare institutions.

R. T · 0 citations
Open access Aug 2026

An Explainable AI-Driven Framework for Integrating Diverse Health Data to Enhance Predictive Accuracy and Clinical Interpretability

A framework through XAI to incorporate various health data sources such as electronic health records, medical imaging, laboratory reports, and wearable sensor information, which can be integrated in the context of achieving higher predictive performance in disease prediction and treatment stratification, as well as decision-making transparency.

M. Aparna, S. Lahane, Dr. Bharti A. Dixit · 0 citations
Review Aug 2026

AI-based multimodal integration of genomics and electronic health records.

This Review highlights AI and ML frameworks for integrating genomic, multi-omics, and EHR data, and discusses how these approaches are reshaping genomics research as well as clinical practice.

Rasika Venkatesh, M. Ritchie · 0 citations
Review Open access Aug 2026

Explainable AI in Healthcare: A Comparative Analysis of Interpretability Techniques for Clinical Decision Support Systems

It is concluded that explainable artificial intelligence improves trust, reliability, and accountability in healthcare systems and is a prerequisite for successful integration of intelligent technologies into clinical practice.

Riya Jacob K · 0 citations
Review Aug 2026

CAUSAL artificial intelligence and data-driven decision intelligence in personalized medicine: a review of healthcare informatics systems.

This review examines the integration of causal artificial intelligence (AI) and data-driven decision intelligence within healthcare informatics systems to advance personalized medicine and clinical decision-making. A narrative review methodology was employed, synthesizing interdisciplinary literature from major databases, including PubMed, Scopus, Web of Science, IEEE Xplore, and ScienceDirect. Studies focusing on causal inference, decision intelligence, and healthcare informatics applications in personalized medicine were included. Data were extracted on methodological approaches, healthcare settings, analytical techniques, and clinical applications, followed by thematic synthesis. Findings indicate that causal AI enhances clinical decision support by enabling estimation of treatment effects and simulation of intervention outcomes at the individual patient level. Integration of multimodal health data such as electronic health records, genomic data, and real-time monitoring improves prediction accuracy and supports tailored treatment strategies. Additionally, causal models improve interpretability, fostering clinician trust and facilitating transparent decision-making. Robust healthcare informatics infrastructures, including interoperable systems and data warehouses, were identified as critical enablers of causal analytics. Overall, causal AI represents a transformative advancement in healthcare analytics, supporting more informed, individualized, and evidence-based clinical decisions. Its integration within healthcare informatics systems has significant potential to improve patient outcomes and guide the future of intelligent, personalized healthcare delivery.

Mohammed Majid Bakhsh, Emran Hossain, M. K. K. Rony et al. · 0 citations
Open access Aug 2026

Towards Predictive, Preventive, and Participatory Care: The Promise of Personalized Medicine

Personalized medicine is a transformative healthcare approach that designs prevention, diagnosis, and treatment to each individual’s unique genetic, molecular, and environmental profile. By integrating multi-omics technologies—genomics, transcriptomics, proteomics, and metabolomics—with advanced computational analytics, it enables early disease prediction, precise classification, and patient-specific therapy design. Advances in next-generation sequencing, artificial intelligence, and additive manufacturing, including 3D printing, have driven pharmacogenomic drug optimization, biomarker-guided targeted therapies, and on-demand production of customized dosage forms. Clinical applications span oncology, infectious, cardiovascular, neurological, and rare genetic diseases, improving therapeutic precision, reducing adverse effects, and enabling proactive disease management. Key benefits include more accurate drug-response prediction, fewer treatment failures, enhanced patient safety, and long-term economic savings through reduced healthcare utilization. However, widespread adoption faces challenges such as high cost, limited access in low-resource settings, and protection of sensitive genomic data. Ethical concerns—privacy, informed consent, and equitable benefit sharing—require robust regulation and public engagement. Future progress depends on expanding genomic diversity, building curated multi-omics repositories, and leveraging AI for biomarker discovery and predictive modeling. Emerging innovations in continuous manufacturing and flexible 3D printing will support individualized small-batch drug production, while adaptive policy frameworks must ensure safety, affordability, and accessibility. With coordinated scientific, technological, and ethical efforts, personalized medicine promises predictive, preventive, precise, and participatory healthcare worldwide.

Janhavi Patil, Diya H. Aga, Sneha Yadav et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.